Monosymptomatic enuresis: the therapeutic weapons


Article ID: 6796
Vol 33, Issue 5S1, 2019
DOI: https://doi.org/10.54517/jbrha6796
Received: 8 November 2019; Accepted: 8 November 2019; Available online: 8 November 2019; Issue release: 8 November 2019

Abstract

Nocturnal enuresis (NE) was defined by the World Health Organization (ICD-10) and the American Psychiatric Association (DSM-5) as bed-wetting in children aged >5 years. In cases of mental retardation, the developmental age may be equivalent to 5 years. In this review, we focus on the current knowledge about the etiology of enuresis and the most recent therapeutical options. Both non-pharmacological and pharmacological therapies are included, although the relative effectiveness of each remains uncertain. To date, motivational, alarm and drug therapies are the mainstay of treatment. Alarm therapy remains the first-line treatment modality for NE, while desmopressin is the most commonly used medical treatment.


Keywords

enuresis;urinary control;alarm system;desmopressin


References

Supporting Agencies



Copyright (c) 2019




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).